Ikarian Capital’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $1.85M | Buy |
|
|||||
|
2024
Q3 | $285K | Sell |
|
|||||
|
2024
Q2 | $376K | Sell |
|
|||||
|
2024
Q1 | $813K | Buy |
|
|||||
|
2023
Q4 | $353K | Hold |
|
|||||
|
2023
Q3 | $315K | Hold |
|
|||||
|
2023
Q2 | $451K | Hold |
|
|||||
|
2023
Q1 | $585K | Hold |
|
|||||
|
2022
Q4 | $506K | Hold |
|
|||||
|
2022
Q3 | $558K | Sell |
|
|||||
|
2022
Q2 | $756K | Sell |
|
|||||
|
2022
Q1 | $1.51M | Buy |
|
|||||
|
2021
Q4 | $1.89M | Sell |
|
|||||
|
2021
Q3 | $3.32M | Sell |
|
|||||
|
2021
Q2 | $5.7M | Sell |
|
|||||
|
2021
Q1 | $10.2M | Hold |
|
|||||
|
2020
Q4 | $15.7M | Sell |
|
|||||
|
2020
Q3 | $12.2M | Buy |
|
|||||
|
2020
Q2 | $15.5M | Buy |
|
|||||
|
2020
Q1 | $10.4M | Buy |
|
|||||
|
2019
Q4 | $138K | Buy |
|